Miruvor
Sign up
Long COVID Outcome unclear

Long COVID with insomnia, dysautonomia, PEM and MCAS; extreme sensitivity to low-dose LDN

Condition
Long COVID
At worst
Not stated
Ill for
Not stated
Last post
May 2026
In their words
Read from 1 of their posts and comments; links to the one this page draws on

Request to remove this story

Summary

Lagoon 20986 described insomnia, dysautonomia, PEM, MCAS and fatigue issues, and extreme sensitivity to low doses of medications and supplements. A 0.01 mg dose of LDN was enough to worsen all of these symptoms. They were currently looking at tackling the MCAS issue, which they called low-hanging fruit, and said KPV sounded well tolerated.

Ask Miruvor AI

Asking aboutLagoon 20986’s story

What they tried

Also tried

Their words about each treatment
  • LDN · WorseJust .01 mg of LDN was enough to set my system off. Insomnia, dysautonomia, PEM, MCAS, and fatigue issues all get worse. In context ↗

Their path

They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.

WhenWhat happenedAfter
2026-05-290.01 mg LDN set system off and worsened insomnia, dysautonomia, PEM, MCAS and fatigue.01 mg of LDN was enough to set my system off. ... Insomnia, dysautonomia, PEM, MCAS, and fatigue issues all get worse. In context ↗Low-dose naltrexone
2026-05-29Still symptomatic; considering MCAS treatmentI'm currently looking at tackling the MCAS issue as it seems like low-hanging fruit In context ↗

Adverse events

  • Low-dose naltrexone“Just .01 mg of LDN was enough to set my system off. Insomnia, dysautonomia, PEM, MCAS, and fatigue issues all get worse.” In context ↗ Made symptoms worse

Ask Miruvor AI

Asking aboutLagoon 20986’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime